Tchekmedyian V, Dunn L, Sherman EJ, Baxi SS, et al. Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial. Thyroid 2022 Jan 19. doi: 10.1089/thy.2021.0565.
PMID: 35045748